Published in Hepatitis Weekly, June 30th, 2003
The investigators work at the Guys Kings' and St. Thomas School of Medicine in London, U.K., where they analyzed the liver biopsies of 135 patients with HCV infections and 55 others coinfected with HIV. Researchers used statistical analysis to identify those elements most likely to correlate with fibrosis progression among the study enrollees.
"The estimated median fibrosis progression rate was 0.17 units/year...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.